Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile.
Open | $6.500 |
Close | $6.250 |
Volume / Avg. | 1.952M / 992.352K |
Day Range | 5.900 - 6.500 |
52 Wk Range | 1.280 - 16.240 |
Market Cap | $417.873M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 10.49% |
Days to Cover | 5.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nkarta (NASDAQ: NKTX) through any online brokerage.
Other companies in Nkarta’s space includes: Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and TScan Therapeutics (NASDAQ:TCRX).
The latest price target for Nkarta (NASDAQ: NKTX) was reported by Canaccord Genuity on Friday, May 10, 2024. The analyst firm set a price target for 15.00 expecting NKTX to rise to within 12 months (a possible 152.95% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Nkarta (NASDAQ: NKTX) is $5.93 last updated May 10, 2024 at 6:55 PM EDT.
There are no upcoming dividends for Nkarta.
Nkarta’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Nkarta.
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.